Sunnova Receives Continued Listing Notice from NYSE
The NYSE rules require the Company to notify the NYSE, within 10 business days of receipt of the Notice, of its intent to cure the share price deficiency. The Company has six months following the receipt of the Notice to cure the deficiency and regain compliance. The Company can regain compliance at any time during the six-month cure period if, on the last trading day of any calendar month during the cure period, its common stock, par value
The Company will closely monitor the closing share price of its Common Stock and is considering all available options and intends to regain compliance with the NYSE listing standards by pursuing measures that are in the best interests of the Company and its shareholders, including potentially through the consummation of a reverse stock split, subject to approval by the Company’s board of directors and shareholders.
During the cure period, the Common Stock will continue to be listed and traded on the NYSE under its existing ticker symbol, with the addition of a suffix indicating the “below compliance” status of the Common Stock, as “NOVA.BC.”
The Notice does not affect the Company’s business operations, or its
About Sunnova
Forward Looking Statements
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or the Company’s future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "going to," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these words or other similar terms or expressions that concern the Company’s expectations, strategy, priorities, plans or intentions. Forward-looking statements in this release include, but are not limited to, statements regarding the Company’s ability to regain compliance with the NYSE’s continued listing standard, the Company’s intention to seek a reverse stock split and the Company’s ability to successfully execute its business and financial strategies. All statements, other than statements of historical fact, are forward-looking statements. Any such forward-looking statements may involve risk and uncertainties that could cause actual results to differ materially from any future results encompassed within the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the risks and other important factors discussed under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended
View source version on businesswire.com: https://www.businesswire.com/news/home/20250404388341/en/
Sunnova Media Contact
203-581-2114
russell.wilkerson@sunnova.com
Sunnova Investor Contact
877-770-5211
IR@sunnova.com
Source: